Ganitumab and Gemcitabine Hydrochloride Followed by Radiation Therapy, Ganitumab, Capecitabine, and Maintenance Therapy in Treating Patients With Locally Advanced Cancer of the Pancreas

NCT01298401 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

NETWORK

Sponsor class

Conditions

Pancreatic Cancer

Interventions

BIOLOGICAL: ganitumab
DRUG: capecitabine
DRUG: gemcitabine hydrochloride
RADIATION: 3-dimensional conformal radiation therapy

Sponsor

Radiation Therapy Oncology Group

Collaborators

[object Object]
[object Object]